According to Relmada Therapeutics's latest financial reports the company's current earnings (TTM) are -$86.77 M. In 2023 the company made an earning of -$98.8 M an increase over its 2022 earnings that were of -$0.16 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.